Katell Le Lay
La Defense, 92060, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Adopting a Societal Perspective in Health-Economic Evaluation: Analysis of Nine HTA Methodological Guidelines on How to Integrate Societal Costs.
Journal: Journal of market access & health policy
Published: November 20, 2025
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance.
Journal: Journal of market access & health policy
Published: January 26, 2024
Cost-effectiveness analysis of atezolizumab as adjuvant treatment of patients with stage II-IIIA non-small cell lung cancer, PD-L1+≥50% of tumor cells in France: A modeling study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 20, 2023
Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.
Journal: Journal of market access & health policy
Published: June 17, 2022
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Journal: Respiratory research
Published: February 25, 2021
Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France.
Journal: Journal of scleroderma and related disorders
Published: January 07, 2021
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study.
Journal: Future oncology (London, England)
Published: May 01, 2020
Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model.
Journal: International journal of chronic obstructive pulmonary disease
Published: November 01, 2019
Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France.
Journal: Current medical research and opinion
Published: January 26, 2019
Health economic evaluation in idiopathic pulmonary fibrosis in France.
Journal: Current medical research and opinion
Published: January 26, 2018
Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: November 11, 2017
Last Updated: 09/26/2026